Trial Profile

PATCAR Pilot Trial: A Phase 4 Study, Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Reteplase (Primary)
Indications Coronary artery restenosis; Embolism and thrombosis; Myocardial infarction
Focus Therapeutic Use
Acronyms PATCAR

11 Aug 2023 The protocol has been amended as above-1) Number of arms has been changed from 2 to 4. 2)Promary endpoint has been amended (time frame has been changed from 1 year to 30 days).3) Actual patient number changed from 254 to 390.4) In design parallel and randomized model have been implemented.
28 Feb 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
09 Feb 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com